Hypertrophic cardiomyopathy: open trials in Portugal

• NCT07023614

  A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

  Trial Treatment · Phase 2 · Imbria Pharmaceuticals, Inc.

  Guimarães · Lisbon

  Registry updated 2026-10-26

• 2024-515125-28-00

  A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

  Trial Treatment · Phase 2 · Imbria Pharmaceuticals Inc.

  Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude De Sao Jose E.P.E., Lisbon · Hospital da Luz, S.A, Lisbon · Hospital Cuf Descobertas S.A., Lisbon

  Registry updated 2026-10-19

• NCT04848506

  Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

  Trial Treatment · Phase 2/3 · Cytokinetics

  Unidade Local De Saude Da Regiao De Aveiro E.P.E., Aveiro · Unidade Local De Saude De Sao Jose E.P.E., Lisbon · Hospital Cuf Descobertas S.A., Lisbon · Hospital da Luz, S.A, Lisbon

  Registry updated 2026-10-13

All Hypertrophic cardiomyopathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error